Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

1.1. Термины и определение Болезнь Крона (БК)–хроническое, рецидивирующее
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …

Crohn's disease (CD) accounts for a variety of clinical manifestations or phenotypes that
stem from chronic inflammation in the gastrointestinal tract. Its worldwide incidence is …

Therapeutic drug monitoring (TDM), which involves measurement of drug or active
metabolite levels and anti-drug antibodies, is a promising strategy that can be used to …

Background Therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD)
patients receiving anti‐tumour necrosis factor (TNF) agents can help optimise outcomes …

The inflammatory Bowel diseases (IBDs) are a chronic, relapsing inflammatory diseases of
the gastrointestinal tract with heterogeneous behavior and prognosis. The introduction of …

Background & Aims Mucosal healing is an independent predictor of sustained clinical
remission in patients with ulcerative colitis (UC) treated with infliximab. We investigated …

Background & Aims A subset of patients with Crohn's disease (CD) do not respond to
ustekinumab at the standard dose of 90 mg every 8 weeks. Little is known about the efficacy …